Chemical and pharmacological significance of 1,4-dihydropyridines - A review

Indian Drugs

Volumn 44, Issue 2, 2007, Pages 73-90

  Pattan, S R ^a   Parate, A N ^a   Sirisha, K ^a   Achaiah, G ^a   Reddy, V M ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

1,4 dihydropyridines; Antihypertensives; Calcium antagonists; Chemosensitizers; MDR cancer

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

CANCER CELL; NEOPLASM; SYNTHESIS; THROMBOCYTE AGGREGATION INHIBITION;

EID: 55649085091     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. 2+ channels. Nature, 1983, 303, 535-7. (Pubitemid 13054623)
2. Phillips A. P., Randall L. O., U. S. Patent, 2, 359, 329, 1944.
3. Bernard Loev, Hantzsch-type dihydropyridine hypotensive agents. J Med. Chem., 1974, 17, 956-65.
4. Takenaka T., Usuda S., Nomura T., Maeno H., Sado T. Vasodilator prof ile of a new 1, 4-dihydropyridine derivative. 2, 6-dimethyl-4-(3-nitrophenyl)-1, 4-dihydropyridine-3, 5-dicarboxylic acid 3-[2-(N-benzyl-N-methyl amino)]ethyl ester 5-methyl ester hydrochloride (YC-93). Arzneim Forsch., 1976, 26, 2172-8.
5. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol., 1977, 17, 149-66.
6. Iwanami M., Shibanama T., Fujimoto M., Kawai R., Tamazawa K., Takenaka T., Murakami M. Synthesis of new water-soluble dihydropyridine vasodilators. Chem Pharm Bull., 1979, 27, 1426-40. (Pubitemid 9237112)
7. Bossert F., Meyer H., Wehinger E. 4-Aryl dihydropyridines, a new class of highly active calcium antagonists. Angew Chem., 1981, 93, 755-63. (Pubitemid 11028866)
8. Kuthan J., Kurfurst A. Developments in dihydropyridine chemistry. Ind Eng Chem Prod Res Dev., 1982, 21, 191-261.
9. Bossert F., Meyer H., Wehinger E., 4-Aryldihydropyridines, a new class of highly active calcium antagonists. Angew Chem Int Ed Engl., 1981, 20, 762-69. (Pubitemid 12229067)
10. Takenaka T., Maeno H., A new vasoconstrictor 1, 4-dihydropyridine derivative YC-170. Jpn J Pharmacol., 1983, 32, 139-40.
11. Stout D. M., Meyers A. L Recent advances in the chemistry of dihydropyridines. Chem. Rev., 1982, 82, 223-43.
12. Bossert F., Vater W., Nifedipine and some related 4-aryl-1, 4-dihydropyridines. US Patent, 1969, 3, 485, 847, Dec. 23.
13. Meyer V. H., Bossert F., Vater W., Stoepel K., 2-Amino 4-pyrimidyl-1, 4-dihydropyridine derivatives. US Patent, 1974, 4, 022, 898.
14. Meyer V. H., Bossert F., Wehinger K., Stoefel K., Vater W., Synthesis and comparative pharmacological studies of 1, 4-dihydro-2, 6-dimethyl-4-(3- nitrophenyl) pyridine-3, 5-dicarboxylates with non identical ester functions. Arzneim-Forsch, 1981, 31, 407-9. (Pubitemid 11056544)
15. Galiano A., Elgodipine. Drugs Fut., 1995, 20, 231-34.
16. Alajarin R., Vaquero J. J., Alvarez-Builla J., Pastor M., Sunkel C, de Casa-Juana M. F., Priego J., Stotkow P. R., Sanz-Aparicio J., Synthesis and chromatographic separation of the stereoismomers of furnidipine. Tetrahedron Asymmetry, 1993, 4, 617-20. (Pubitemid 23115060)
17. Alajarin R., Alvarez-Builla J., Vaquero J. J., Sunkel C, de Casa Juana., Synthesis, structure and pharmacological evaluation of the stereoisomers of furnidipine. J Med Chem., 1995, 38, 2830-41.
18. Sannita W. A., Busico S., Di Bon G., Ferrari A., Riela S., Pharmacokinetics and electroencephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in human volunteers. Int. J. Clin. Pharmacol. Res., 1993, 13, 281-91. (Pubitemid 24068356)
19. Uehara Y., Kawabata Y., Ohshima N., Hirawa N., Takada S., Numabe A., Nagata T., Goto A., Yagi S., Omata M. New dihydropyridine calcium channel antagonist, pranidipine, attenuates hypertensive renal injury in Dahl salt-sensitive rats. J Cardiovasc Pharmacol., 1994, 23, 970-79. (Pubitemid 24166662)
20. Nakagawa T., Yamauchi Y., Kondo S., Fiji M., Yokoo N., Antihypertensive effects of Lemildipine (NB-818), a new dihydropyridine derivative, in normotensive and hypertensive animal model. Jpn J Pharmacol., 1994, 64(1), 260-65.
21. Boer R., Gekeler V. Chemosensitizer in tumor therapy: New compounds promise better efficacy. Drugs Fut., 1995, 20, 499-509.
22. McCormack P. L, Waqstaff A. J., Lacidipine: A review of its use in the management of hypertension. Drugs, 2003, 63(21), 2327-56. (Pubitemid 37330535)
23. Gao F., Gong B., Christopher AT., Lopez B. L, Ma X. L, Anti-apoptotic effect of benidipine, a long lasting vasodilating calcium antagonist in Ischaemic/reperfused myocardial cells. Brit J Pharmacol., 2001, 132, 869-78. (Pubitemid 32193644)
24. Sunkel C. E., de Casa-Juana M. F., Santos L, Garcia A. G., Artaljero C. R., Vilaroya M., Gonzalez-Morales M. A., Lopez M. G., Cillero J., Alonso S., Priego J. G. Synthesis of 3-[(2, 3-dihydro-1, 1, 3-trioxo-1, 2-benzisothiazol-2-yl) alkyl]-1, 4-dihydropyridine-3, 5-dicarboxylate derivatives as calcium channel modulators. J Med Chem., 1992, 35, 2407-14.
25. Vo D., Matowe W. C., Ramesh M., Iqbal M., Wolowyk M. W., Howlett S. E., Knaus E. E. Synthesis, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1, 4-dihydro-2, 6-dimethyl-3-nitro-4- pyridinyl pyridine-5-carboxylate racemates and enantiomers. J Med Chem., 1995, 38, 2851-59.
26. Hansson L, Calcium antagonists: An overview. Am Heart J., 1991, 122, 308-11.
27. Pickard J. D. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Brit Med J., 1989, 298, 636-42. (Pubitemid 19088521)
28. Jan M., Buchbeit F., Tremoulet M., Therapeutic trial of intravenous nimodipine in patients with established' cerebral vasospasm after rupture of intracranial aneurysms. Neurosurg, 1988, 23, 154-57.
29. Reicher-Reiss H., Barasch E., Calcium antagonists in patients with heart failure: A review. Drugs, 1991, 42(3), 343-64. (Pubitemid 21920767)
30. Gelmers H. J., Henneric N., Effect of nimodipine on acute ischemic stroke: Pooled results from five randomized trials. Stroke, 1990, 21, 81-4.
31. Di Bona G. F., Epstein M., Mann J., Nordlander M. Effect of different dihydropyridine-type Ca2+ antagonists on kidney. Kidney Int., 1991, 41(36), 100-5.
32. Bretzel R. G., Bollen C. C., Maeser E., Federlin, F. F., Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients. Am. J Kidney Dis., 1993, 21, 53-64. (Pubitemid 23180378)
33. Triggle D. J., Langs D. A., Janis R. A., Ca2+ channel ligands: Structure-function relationships of 1, 4-dihydropyridines. Med Res Rev., 1989, 9(2), 123-80. (Pubitemid 19087406)
34. Godfraind T., Miller R., Wibo M. Calcium antagonism and calcium entry blockade - Review. Pharmacol Rev., 1986, 38, 321-416. (Pubitemid 17229059)
35. Chapman R. W., Danko G., Siegel M. J. Effect of extraand intracellular calcium blockers on histamine and antigen-induced bronchospasms in guinea pigs and rats. Pharmacology, 1984, 29, 282-91. (Pubitemid 14048912)
36. Dodd J. H., Charles S. F., John M. R., David R. M., Yolando G. N., Deborah L., Sandra M., Design and discovery of RWJ 2208 - A novel bronchoselective calcium channel blocker. Drug Des Discovery, 1998, 15, 135-48. (Pubitemid 28301997)
37. Sausins A., Duburs G., Synthesis of 1, 4-dihydropyridines by cyclocondensation reactions. Heterocycles, 1988, 27. 269-89.
38. Magar P. P., Coburn R. A., Solo A. J., Triggle D. J., Rothe H., QSAR, diagnostic statistics and molecular modeling of 1, 4-dihydropyridine calcium antagonists: a difficult road ahead. Drug Design Discovery, 1992, 8, 273-89.
39. Mannhold R., Joblonka B., Voigdt W. Schoenafinger K., Schravan K., Calcium and calmodulin-antagonism of elnadipine derivatives: A comparison of structure-activity relationships. Eur J Med Chem., 1992, 27, 229-35.
40. Jiang J., Van Rhee A. M., Chang L., Patchornik A., Ji X. D., Evans P., Melman N., Jacobson K. A., Structure activity relationships of 4-(phenylethynyl)-6-phenyl-1, 4-dihydropyridines as highly selective A3 adenosine receptor antagonists. J Med Chem., 1997, 40, 2596-608. (Pubitemid 27347025)
41. Li A. H., More S., Melman N., Ji X., Jacobson K. A., Structure-activity relationships and molecular modeling of 3, 5-diacyl-2, 4-dialkyl pyridine derivatives as selective A3 adenosine receptor antagonist. J Med Chem., 1998, 41, 3186-95.
42. Klusa V. Cerebrocrast (10S-1. 1212) Neuroprotectant, Cognition enhancer. Drugs Fut., 1995, 20, 135-8.
43. Cooper K., Fray M. J., Parry M. J. 1, 4-Dihydropyridines as antagonists of platelet activating factor. Synthesis and structure-activity relationships of 2-(4-heterocyclyl) phenyl derivatives. J Med Chem., 1992, 35, 3115-29.
44. Wong Wai C, George C, John W., Mohammad M. R., Dhanpalan N., Diana W., James F., Herbert L, Identification of a dihydropyridine as a potent a1a adrenoceptor selective antagonist that inhibits phenylephrine-induced contraction of the human prostate. J Med Chem., 1998, 41, 2643-50.
45. Donkar I. O., Zhou X., Jeffery S., Krishna A. C., Kishore V., Synthesis and radioprotective effect of adamantyl substituted 1, 4-dihydropyridine derivatives. Bioorg Med Chem., 1998, 6, 563-8. (Pubitemid 28264078)
46. Hantzsch A., Justus Liebigs., Hantzsch pyridine synthesis. Ann Chem., 1882, 215, 1-81.
47. Collie J. N., Justus Liebigs., Hantzsch synthesis of symmetrical 1, 4-dihydropyridines from b-aminocrotonates. Ann Chem., 1884, 256, 294-306.
48. Lachowicz B., 1, 4-Dihydropyridine carboxylic acids. Monatsh Chem., 1896, 17, 343-57.
49. Emmert B., Diefenbach E., Eck R., 1-Aryl and 1-benzyl-3, 5-diethoxycarbonyl-1, 4-dihydropyridines. Ber., 1927, 60, 2216-20.
50. Taber W., Karner P., Synthesis and antihypertensive activities of new 1, 4-dihydropyridine derivatives. Helv Chim Acta, 1958, 41, 2066-80.
51. Brignell P. G., Eisner U., Farrell P. G., Substituent effect in the ultraviolet spectra of 1, 4-dihydropyridines. J. Chem. Soc, 1966, 8, 1083-95.
52. Palecek J, Ptackova L, Kuthan J, Reactions of esters of dinicotinic acid. Collect Czech Chem Commun, 1969, 34, 427-31.
53. Dubur G, Ogle Z, Uldrikis R, Synthesis of mono substituted amides of 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylic acid. Chem Heterocycl Compds., 1974, 1642-44.
54. Gelbard G, Lin J., Roques N, Reductions with NADH models. The high reactivity of Hantzsch amides. J Org Chem., 1992, 57, 1789-93.
55. Fossheim R., Svarteng K., Mostad A., Romming C, Sheffer E., Triggle J. D., Crystal structures and pharmacological activity of calcium channel antagonists: 2, 6-dimethyl-3, 5-dicarbomethoxy-4-(unsubstituted, 2-methyl, 4-methyl, 3-nitro, 4-nitro and 2, 4-dinitrophenyl) - 1, 4-dihydropyridine. J Med Chem., 1982, 25, 126-31. (Pubitemid 12106630)
56. Eiden F., Braatz K., Greeske., High performance liquid chromatographic assay of nitrendipine. D. A. Z., 1983, 123, 2003-5.
57. Alajarin R., Vaquero J. J, Garcia N. J, Alvarez B. J., Synthesis of 1, 4-dihydropyridines under microwave irradiation. Syn Lett, 1992, 297-98.
58. Alajarin R., Jordan P., Vaquero J. J., Alvarez B. J, Synthesis of unsymmetrically substituted 1, 4-dihydropyridines and analogous calcium antagonists by microwave heating. Synthesis, 1995, 389-91.
59. Zhang Y. W, Shen Z. X, Pan B, Lu X. H, Chen M. H, Research on the synthesis of 1, 4-dihydropyridines under microwave. Synth Commun, 1995, 25, 857-62.
60. Khadilkar B, Chitnavis A, Rate enhancement in the synthesis of some 4-aryl-1, 4-dihydropyridine using methyl-3-aminocrotonate under microwave irradiation. Indian J Chem, 1995, 34 B, 652-53.
61. Gordeev M. F., Patel D. V, Gordon E. M, Approaches to combinatorial synthesis of heterocycles: A solid-phase synthesis of 1, 4-dihydropyridines. J Org Chem, 1996, 61, 924-28; (Pubitemid 26066987)
62. Gordeev M. F, Patel D. V, Gordon E. M, Approaches to combinatorial synthesis of heterocycles: Solid phase synthesis of pyridines and pyrido[2, 3-d]pyrimidines. Tetrahedron Lett, 1996, 37(27), 4643-46. (Pubitemid 26225545)
63. Gordeev M. F, Patel D. V, England B. P, Supriya J, Combinatorial synthesis and screening of a chemical library of 1, 4-dihydropyridine calcium channel blockers. Bioorganic & Medicinal Chemistry, 1998, 6, 883-89. (Pubitemid 28464518)
64. Saurez M, Loupy A, Perez E, Moran L, Gerona G, Morales A, An efficient procedure to obtain hexahydroquinolines and unsymmetrical, 1, 4-dihydropyridines using solid inorganic supports and microwave activation. Heterocycl Commun, 1996, 2, 275-80. (Pubitemid 126459954)
65. Penieres, A modification to the Hantzsch method to obtain pyridines in a one-pot reaction. Use of a bentonitic clay in a dry medium. Heterocycl Commun., 1996, 2, 359-60.
66. Fuji Masayuki, Rikogaku-hen, 1997, 26, 17.
67. Khadilkar B. M, Sadvilar V. G, Gaikar V. G, Aqueous solutions of hydrotropes as effective reaction media for the synthesis of 4-aryl-1, 4-dihydropyridines. J Chem Technol Biotechnol, 1995, 63, 33-6.
68. Swamy S. K, Reddy T. M, Reddy V. M, Synthesis and evaluation of new4-aryl/heteroaryl-3, 6-dimethyl-3, 5-bis-N (arylcarbamoyl)-1, 4-dihydro-pyridines. Indian J Pharm Sci, 1998, 60(2), 102-6.
69. Swamy S. K, Prabhakar M. C, Reddy V. M, Synthesis and evaluation of new 4-aryl/heteroaryl-3, 6-dimethyl-3, 5-bis-N (aryl-carbamoyl)-1, 4-dihydro pyridines. Indian Drugs, 1998, 35(8), 150-6.
70. Reddy V. M, AAPS Annual Meeting and Exposition held at Denves, USA during Oct. 21-25, 2001, Abst. No. 1245.
71. Reddy V. M, Annual Meeting and exposition held at Denves, USA during Nov. 10-14, 2002, Abst. No. M 1178.
72. Yadav J. S, Subba Reddy V. B., Thirupathi Reddy P., Unprecedented synthesis of Hantzsch 1, 4-dihydropyridines under Biginelli reaction conditions. Syn Commun, 2001, 31(3), 425-30. (Pubitemid 32231824)
73. Anniyappan N., Muralidharan D., Perumal, P. T., Synthesis of Hantzsch 1, 4-dihydropyridines under microwave irradiation. Syn Commun., 2002, 32(4), 659-63. (Pubitemid 34194715)
74. Torchy S., Cordonnier G., Barbry D., Vanden Eyende J. J., Hydrogen transfer from Hantzsch 1, 4-dihydropyridines to carbon-carbon double bonds under microwave irradatiation. Molecules, 2002, 7, 528-33. (Pubitemid 38982511)
75. Illescas B., Martinez-Grau M. A., Torres M. L., Gadea J. F., Martin N., Synthesis of new C60 derivatives containing biologically active 4-aryl-1, 4-dihydropyridines. Tetrahedron Letters, 2002, 43, 4133-36. (Pubitemid 34603169)
76. Sabitha G., Kiran Kumar Reddy G. S., Srinivas Reddy Ch., Yadav J. S., A novel TMSI-mediated synthesis of Hantzsch 1, 4-dihydropyridines at ambienttemperatures. Tetrahedron Letters, 2003, 41 29-31.
77. Vanden Eynde J. J., Mayence A., Synthesis and aromatization of Hantzsch 1, 4-dihydropyridines under microwave irradiation. An overview, Molecules, 2003, 8, 381-91. (Pubitemid 38990391)
78. Zolfigol M. A., Safaiee M., Synthesisof 1, 4-dihydropyridines under solvent free conditions. Synlett., 2004, 827-8.
79. Wang G. W., Xia J. J., Miao C. B., Wu X. L, Environmentally friendly and efficient synthesis of various 1, 4-dihydropyridines in pure water. Bulletin of the Chemical Society of Japan, 2006, 79(3), 454-9.
80. Heravi M. M., Moosavi F. S. S., Beheshtiha Y. S., Ghassamzadeh M., Manganese dioxide supported onto HZSM-5 zeolite, a versatile reagent for the aromatization of Hantzsch 1, 4-dihydropyridines. Heterocyclic Commun., 2004, 10(6), 415-8. (Pubitemid 40017491)
81. Heravi M. M., Derikvand F., Oskooie H. A., Shoar R. H., Silica gel-supported bis (trimethylsilyl) chromate: Oxidation of 1, 4-dihydropyridines to pyridines. Syn Commun., 2006, 36, 77-82. (Pubitemid 43111843)
82. Yadav J. S., Reddy B. V. S., Basak A. K., Baishya G., Venkat Narsaiah A., Lodoxybenzoic acid (IBX): An efficient and novel oxidizing agent for the aromatization of 1, 4-dihydropyridines. Synthesis, 2006, 3, 451-4. (Pubitemid 43241455)
83. Ger. Offen, 2228377 (CL. C07 D) 03 Jan, 1974;
84. Appli. P22, 283778 10 Jan 1972, 44 pp;
85. Ger. Offen 2525277 (CL C07 D) 18 dec. 1975;
86. Jpn. Kokai 75140463 (CI, C07, DA61k) 11 Nov. 1995;
87. Jpn. Kokai 76133272 (CI. Co & D 211/90) 18 Jan. 1978;
88. Chem. Abstr. 75, 47266e (1971);
89. Chem. Abstr., 75, (1971) 98407j.
90. Bellemann P., Ferry F., Lubbecke, Glossman M., [3H]-nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzeim-Forsch, 1981, 31, 2064-7. (Pubitemid 12248443)
91. Palecek J., Manfred P., Kuthan J., Phase-transfer catalysis in the N-alkylation of 1, 4-dihydropyridines. Collect Ezech Chem Commun., 1983, 48, 608-16;
92. Chem. Abstr., 1983, 9821545k.
93. Janis R. A., Triggle D. J., New developments in Ca2+ channel antagonists. J Med Chem., 1983, 26, 775-85. (Pubitemid 13100458)
94. Langs D. A., Triggle D. J., Conformational features of calcium channel agonist and antagonist analogs of nifedipine. Mol Pharmacol., 1985, 27, 544-8. (Pubitemid 15098311)
95. Mahmoudian M., Richards W. G., QSAR of binding of dihydropyridine-type calcium antagonists to the receptor on ileal smooth muscle preparations. J. Pharm. Pharmacol., 1986, 38, 272-6. (Pubitemid 16104213)
96. Mahmoudian M., Richards W. G., A conformational distinction between dihydropyridine calcium agonists and antagonists. J. Chem. Soc. Chem. Commun., 1986, 739-41. (Pubitemid 17011726)
97. Kendall, H. E., Luscombe, D. K., Calcium channel blocking drugs. Prog. Med. Chem., 1987, 24, 249-97.
98. Dagnino L., Li-Kwong-Ken M. C., Wolowyk M. W., Triggle C. R., Wynn H., Knaus E. E., Synthesis and calcium channel antagonist activity of Dialkyl-1, 4-dihydro-2, 6-dimethyl-4-(pyridinyl)-3, 5-pyridine carboxylates. J Med Chem, 1986, 29, 2524-9. (Pubitemid 17211414)
99. Dagnino L., Li-Kwong-Ken M. C., Wolowyk M. W., Triggle C. R., Wynn H., Knaus E. E., Synthesis and Ca channel antagonist activity of dialkyl 4-(dihydropyridinyl)-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridine carboxylates. J Med Chem., 1987, 30, 640-6. (Pubitemid 17065197)
100. Campbell S. F., Cross P. E., Burges R. A., Carter A. J., Gardiner D. G., Long-acting dihydropyridine calcium antagonists. Synthesis and structure activity relationships for a series of 2-[(heterocyclyl methoxy) methyl] derivatives. J Med Chem., 1989, 32, 2381-8. (Pubitemid 19245904)
101. Masahiro K., Wada Y., Nagai Y., Nagaoka A., Meguro K., Synthesis and biological activities of optical isomers of 2-(4-diphenyl-1-piperazinyl) ethyl methyl-1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridinedi-carboxylate (Manidipine) dihydrochloride. Chem Pharm Bull., 1989, 37, 2225-8. (Pubitemid 19226541)
102. Fogari R., Mugellini A., Zoppi A., Lazzari P., Maurizio D., Rinaldi A., Preti P., Effect of successful hypertension control by Manidipine or Lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol., 2005, 61(7), 483-90. (Pubitemid 41218819)
103. Ha Sircar, Gregor E. K., Anderson K. R., Haleen S. J., Shih Y. H., Weishaar R. E., Taylor M. D., Calcium channel blocking and positive ionotropic activities of ethyl-5-cyano-1, 4-dihydro-6-methyl-2-[(phenylsulfonyl) methyl]-4-aryl-3-pyridine carboxylate and analogues. Synthesis and structure-activity relationships. J Med Chem., 1991, 34, 2248-60.
104. Cozzi P., Carganico G., Fuser D., Grossoni M., Menichincheri M., Pinciroli V., Vaghi F., Salvati P., lmidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1, 4-dihydropyridines combing Ca2+ antagonism and thromboxane A2 synthase inhibition. J Med Chem., 1993, 36, 2964-72. (Pubitemid 23315401)
105. Carlos S., Casa-Juana M. F., Santos M., Salvador L. A., Garcia A. G., Prego J. M., 1, 4-Dihydropyridinederivatives, a process for their preparation and their use for influencing the blood flow Patent US, 1997, 5691361.
106. Iqbal N., Triggle C. R., Knaus E. E., Novel Hantzsch 1, 4-dihydropyridines to study the structure-function relationships of calcium channels and photoinduced relaxation. Drug Dev Res., 1997, 42, 120-30. (Pubitemid 28243279)
107. Amedeo L, Renzo M. G. P., Rodorto T., Giorgio S., Alberto C, Alberto C, Marco Z., Giorgio B., Dante N., Lercanidipine: A novel dihydropyridine calcium channel blockers. Eur J Med Chem., 1998, 33, 399-420.
108. Massicotte J., Viens A., Yao M. H., Leonardi A., Sironi G., Wang H., Dumont L, Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters. Acta Pharmacologics Sinica, 2003, 24(3), 199-206. (Pubitemid 36286004)
109. Canavesi M., Baldini N., Leonardi A., Sironi G., Bellosta S., Bernini F., In vitro inhibitory effect of Lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages. J Card Pharmacol., 2004, 44, 416-22. (Pubitemid 39305082)
110. Bang L. M., Chapman T. M., Goa K. L., Lercanidipine: A review of its effect in the management of hypertension. Drugs, 2003, 63(22), 2449-72. (Pubitemid 37392913)
111. Catherine H., Makita T., Szlam F., Norlander M., Levy, J. H., The vasodilator effects of Clevidipine on human internal mammary artery. Anesth Analg., 1997, 85, 1000-4. (Pubitemid 27471514)
112. Nordlander M., Sjoquist P. O., Ericsson H., Ryden L., Pharmacodynamic, pharmacokinetic and clinical effects of Clevidipine, an ultra-short acting calcium antagonist for rapid blood pressure control. Cardiovascular Drug Reviews, 2004, 22, 227-50. (Pubitemid 39391191)
113. Tao P., Zheng D. Y., Yu X. J., Effects of intravenous nicardipine in Chinese patients with hypertensive emergencies. Curr Ther Res., 1998, 59, 188-95. (Pubitemid 28140696)
114. Lehmann J., Rainer K., Christoph M., Ansgar S., Kerstin S., Portland. Hantzsch 1, 4-dihydropyridines containing a nitrooxyalkyl ester moiety to study calcium channel antagonist structure activity relationships and nitric oxide release. Press Proa, 1998, 15, 294-305.
115. Ramesh M., Matowe W. C., Murthy A. R., Vo D., Dagnino L.; D-Kwong-Ken M. C., Michael W. W., Knaus E. E., Synthesis and calcium channel modulating effects of alkyl (or cycloalkyl)-1, 4-dihydro-2, 6-dimethyl-3-nitro-4-pyridyl-5- pyridine carboxylate racemates and enantiomers. J Med Chem., 1998, 41, 509-14. (Pubitemid 28093086)
116. Derakhshandeh and Zarghi, A., British Pharmaceutical Conference, 2001, Abstract Book, 233.
117. Zamponi G. W., Stotz S. C., Staples R. J., Andro T. M., Nelson J. K., Hulubei U., Blumenfeld A., Natale N. R. Unique structure-activity relationship for 4-lsoxazolyl-1, 4-dihydropyridines. J Med Chem., 2003, 46, 87-96. (Pubitemid 36043788)
118. Mahmoudian M., Mirkhani H., Nehardani Z., Ghiaaee S., Synthesis and biological activity of two new calciumchannel blockers, mebudipine and dibudipine. J Pharm Pharmacol., 1997, 49, 1229-33. (Pubitemid 28022223)
119. Mahmoudian M., Mebudipine and Dibudipine: A Review. Iranian Journal of Pharmacology & Therapeutics (IJPT), 2003, 2(2), 25-9.
120. Shan R., Velazquez C, Knaus E. E. Synthesis, calcium channel agonist antagonist modulation activities and nitric oxide release studies of nitroxoyalkyl-1, 4-dihydro-2, 6-dimethyl-3-nitro-4-(2, 1, 3-benzoxadiazol-4-yl) pyridine-5-carboxylate. Racemates, Enantiomers and Diastereomers. J. Med. Chem., 2004, 47, 254-61. (Pubitemid 38040509)
121. Visentin S., Rolando B., Di Stilo A., Frutero R., Novara M., Carbone E., Roussel C, Vanthuyne N., Gasco A. New 1, 4-dihydropyridines endowed with NO-donor calcium channel agonist properties. J Med Chem., 2004, 47, 2688-93. (Pubitemid 38580105)
122. Gasco A., Fruttero R., Sorba G., Stilo D. A., Calvino R., No donors: Focus on furoxan derivatives. Pure Appl Chem., 2004, 76, 973-81.
123. Hofmann J., Wolf A., Spitaler M., Bock G., Ueberall F., Egle A., Grunicke H., B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance. Int J Cancer, 1991, 47, 870-4.
124. Tasaka S., Ohmori H., Gomi N., lino N., Machida T., Kiue A., Naito S., Kuwano M., Synthesis and structure-activity analysis of novel dihydropyridine derivatives to overcome multidrug resistance. Bioorg Med Chem Lett., 2001, 11, 275-7. (Pubitemid 32099657)
125. Avendano C, Menendez J. C. Inhibitors of multidrug resistancetoantitumoragents (MDR). Current Medicinai Chemistry, 2002, 9, 159-93.
126. Hofmann J., Wolf A., Spitaler M., Bock G. Reversal of MDR by B 859-35, a metabolite of B 859-35, niguldipine, verapamil and nitrendipine. J Cancer Res Clin Oncol., 1992, 118, 361-6.
127. Zhou X. F., Yang X., Wang Q., Coburn R. A., Morris M. E., Effects of dihydropyridines and pyridines on MDR mediated by breast cancer resistant protein: in vitro and in vivo studies. Drug Metabolism and Disposition, 2005, 33(8), 1220-8. (Pubitemid 41043766)
128. Kawase M., Shah A., Gaveriya H., Motohashi N., Sakagami H., Varga A., Molnar J., 3, 5-Dibenzoy-1, 4-dihydropyridines. Synthesis and MDR reversal in tumor cells. Bioorg & Med Chem., 2002, 10, 1051-5. (Pubitemid 34139920)
129. Saponara S., Kawase M., Shah A., Motohashi N., Molnar J., Ugoc Sai K., Sgaragli G., Fusi F., 3, 5-Dibenzoyl-4-(3-phenoxyphenyl)-1, 4-dihydro-2, 6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility. Brit. J. Pharmacol., 2004, 141, 415-22. (Pubitemid 38297004)
130. Zhou X. F., Coburn R. A., Morris M. E. Effects of new 4-aryl-1, 4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein. J Pharm Sci., 2005, 94(10), 2256-65. (Pubitemid 41665285)
131. Wachter G. A., Davis M. C., Martin A. R., Franzblau S. G. Antimycobacterial activity of substituted isosteres of pyridine and pyrazine carboxylic acids. J Med Chem., 1998, 41(13), 2436-8. (Pubitemid 28285745)
132. Desai B., Sureja D., Naliapara Y., Shah A., Saxena A. K., Synthesis and QSAR studies of 4-substituted phenyl-2, 6-dimethyl-3, 5-bis-N-(substituted phenyl) carbamoyl-1, 4-dihydropyridines as potential antitubercular agents. Biorg & Med. Chem., 2001, 9, 1993-8. (Pubitemid 32739187)
133. Kharkar P. S., Desai B., Gaveria H., Varu B., Loriya R., Naliapara Y., Shah A., Kulkarni V. M., Three-dimensional quantitative structure-activity relationship of 1, 4-dihydropyridines as antitubercular agents. J Med Chem.; 2002, 45, 4858-67. (Pubitemid 35192775)
134. Pattan S. R., Parate A. N. Synthesis of 1, 4-dihydropyridines of biological interest. Indian J Heterocycl Chem., 2003, 12, 387-8.
135. Antikiewiez-Michaluk L, Michaluk J., Romanska I., Vetulani J., Reduction of morphine dependence and potentiation of analgesia by chronic co-adminisration of nifedipine. Psychoparmacology, 1993, 111, 457-64.
136. Briukhanov V. M., Zverev-laf, Elkin, V. I., The effect of calcium antagonists on the development of inflammatory edema in rats. Exp Clin Pharmacol., 1994, 57, 47-9.
137. Sadanandam Y. S., Shetty M. M., Ram Mohan Reddy K., Leelavathi P., Synthesis and pharmacology of new 1, 4-dihydropyridines 2, 6-dimethyl-4- (substituted phenyl) or (2-furyl)-, (2-thienyl) - or (3-pyridyl) - 3, 5-di[(N-methyl) or (N-diethyl)] carbamoyl-1, 4-dihydropyridines as potent calcium channel blockers. Eur J Med Chem., 1994, 29, 975-9.
138. Tripathi A. K., Singh S. P., Jain I. P., Singh S., Ansari N. A., Puri J. N., Sharma M. K. Proceedings of International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, IIMS, Delhi, Dec. 1999.
139. Agudoawu S. A., Knaus E. E., Synthesis and analgesic-anti inflammatory activities of ethyl 2-[3-(1-phenoxy (methoxy) carbonyl-4-ary!-(alkyl)-1, 4-dihydrop yridyl)]acetates. J. Het. Chem., 2000, 37, 303-6.
140. Ono H., Kimura M., Effect of calcium antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil on platelet aggregation in vitro. Arzneim-Forsch Drug Res., 1981, 31, 1131-4. (Pubitemid 12247949)
141. Han P., Boatwright C, Ardlic N. G., Verapamil and collagen-induced platelet reactions-evidence for a role for intracellular calcium in platelet activation. Thromb. Haemostesis, 1983, 50, 537-40. (Pubitemid 13048229)
142. Klaus W., Schror K., Latta G., Darius H., Zeigler R., Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands. Klin-Wochenschr., 1985, 63(1), 16-9 German. (Pubitemid 15155657)
143. Sunkel C. E., de Casa Juana M. F., Santos L, Gomez M. M., Villaroya M., Morales A. G., Preigo J. G., Ortega M. P. 4-Alkyl-1, 4-dihydropyridine derivatives as specific PAF-Acether antagonists. J Med Chem., 1990, 33, 3205-10.
144. Sunkel C. E., de Casa Juana M. F., Cillero F. J., Preigo J. M., Ortega M. P. Synthesis, platelet aggregation inhibitory and in vivo antithrombotic activity of new 1, 4-dihydropyridines. J Med Chem., 1998, 31, 1886-90.
145. Andron Harris R., Psychoactive drugs as antagonists on the action of calcium. In: "New Perspectives on calcium antagonists" American Physiological Society, Betheda, 1963, 223.
146. Tusell J. M., Barron S., Serratosa, Anticonvulsant activity of delta-HCH, calcium channel blockers and calmodulin antagonists in seizures induced by lindane and other convulsant drugs. J Brain Res., 1993, 622(1-2), 99-104. (Pubitemid 23264953)
147. Khanna N., Bhalla S., Sharma K. K. Proceedings of International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, IIMS, Delhi, Dec. 1999.
148. Khosla P., Handu S. S., Pandhi P. Proceedings of International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, IIMS, Delhi, Dec. 1999.
149. Mittal R., Lata S., Guptha S., Saxena K. K., Saxena R. S., Srivastava, Proceedings of International Congress on Frontiers in Pharmacology and Therapeutics in 21st Century, IIMS, Delhi, Dec. 1999.
150. Navidpour L, Shafaroodi H., Miri R., Dehpour Shafiee A., Lipophilic 4-imidazolyl-1, 4-dihydropyridines: Synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizures. Farmaco., 2004, 59, 261-9. (Pubitemid 38471919)
151. Shafiee A., Rastkari N., Zadeh M. S. Anticonvulsant activity of new 1, 4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. DARU, 2004, 12(2), 81-4.
152. Chu C. K., Bhadti V. S., Doshi K. J., Else J. T., Gallo J. M., Boudinet F. D., Schinazi R. F., Brain targeting of anti-HIV nucleosides: Synthesis and in vitro and in vivo studies of dihydropyridines derivatives of 3'-azido-2', 3'-dideoxyuridine and 3'-azido-3'-deoxythymidine. J Med Chem., 1990, 33, 2188-92. (Pubitemid 20236665)
153. Magda A, El-Sherbeny, Al-Salem H. S, Sultan M. A, Radwan M. A., Farag H. A., El-Subhash H. I., Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brain. Archiv der Pharmazie, 2003, 336(10), 445-55. (Pubitemid 37409148)
154. Sheha M., Al-Tayeb A., El-Sherief H., Farag H., New carrier for specific delivery of drugs to the brain. Bioorg & Med Chem., 2003, 11, 1865-72. (Pubitemid 36349167)